chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Aches; Headache; Arm pain; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 12Apr2021 at 11:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety, gluten and mold allergy. Concomitant medications included diclofenac (MANUFACTURER UNKNOWN) and cyclobenzaprine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and unknown if its ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 11:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 21:00, the patient experienced fever, aches, headache, arm pain and exhaustion. No therapeutic measures were taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, aches, headache, arm pain and exhaustion were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I woke up at one with a stomachache and slight headache.  My 7, i experienced aches in joints and body.  I did experience chilling off and on and no appetite.  The next day, I experienced diarrhea and stomach ache.  No appetite.   On Saturday, I was feeling better.  By mid morning, my stomach  was hurting, and I was cold. Still not much of an appetite.  On Sunday,I woke up feeling good.  By 3, I was experiencing extreme exhaustion, chilling, and difficulty breathing.
Tingling, burning sensation, itchy, raised pink/red bumps, and sore in general areas of receiving vaccination.
I have been feeling very week and drowsy.  My throat feels rough and voice is hoarse.
Full body rash described by mother as severe and possibly hives starting 2 days after vaccine.  Patient not seen in office at time of rash.
Came in on 2/11/08 for Bumps over the body for 2 days; Benadryl, Aveeno
Next day - difficulty in raising left arm, warmth at vaccination site. Sunday - shingles rash on arm approximately 2" long, 2" wide
Moderna vaccine was removed from the freezer for more than 30 days when administered.  Receipt was 09/20/2022, administration was 11/15/2022
patient did not have adverse events or reactions, patient received an extra dose  of PCV 13 - last given 2015.
patient came in for a booster shot and she was given the pfizer BioNtech instead of the pfizer BioNTech Bivalent
Patient whom is underage received the Moderna vaccine at our facility on January 03, 2022. We realized the mistake when they came for the second dose on February 18, 2022. Mother stated the only reaction the patient had to the vaccine was a sore arm. The second dose was not  administered at this time due to needing a next course of action from a doctor from the  CDC. The mother was aware of being notified that following Monday with the recommendation. We called her today, February 22, 2022. to let her know that the patient can get 0.3 mL of Pfizer 12+ as the second dose.
Runny nose, sinus pain, headache, sore throat, croupy cough, weakness, generalized body ache, light headedness, malaise, loss of appetite: most sym. much improved in 2 wks. Saw doctor on 10-15-15. TYLENOL, pseudoephedrine, DELSYN, guaifenesin, then antibiotic on 10-15.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004MZ0A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Live, full-term birth) on 19-Dec-2018. Concurrent medical conditions included Asthma (Mild, No maintenance medicine.). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 15-Sep-2020 and the estimated date of delivery was 06-Jun-2021. On 28-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 28-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: abnormal (abnormal) abnormal.
Hives/ rash noted on arms 4/10 in the am then progressed to abdomen and legs, and face.
C/O redness to (L) thigh, two days after vaccines thigh became swollen and did not feel well. C/O tummy ache and nausea, malaise and decreased appetite. Blister.
6 cm hive, Tenderness to right arm, warm to touch, fever, difficulty raising arm, and numbness to right hand.
fatigue, sore throat, cough, SOB, diarrhea, arthralgias, myalgias, headaches
difficulty taking deep breaths; hives on her arm, legs & torso; skin itchiness; prickly red dots, broke out on her arms and legs; Left sore arm where she got injection; This is a spontaneous report from a contactable consumer. This 54-year-old female consumer (patient) reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: FA7484 and expiry date: 30 Sep2021) via intramuscular route of administration on 01Aug2021 at 1200 hours on left arm (at 54-year-old), as dose 1, single for COVID-19 immunization. The patient's medical history included seasonal allergies, she cannot remember the date, maybe in her early 20's was ongoing. History of all previous immunization with the Pfizer vaccine considered as suspect, additional vaccines administered on same date of the pfizer suspect, concomitant medications and relevant tests were reported as none. The patient did not require emergency room and physician office visit. On an unknown date in Aug2021 she just experienced left sore arm where she got the shot. She did not provide the start date and outcome. Within 2 days, on 04Aug2021, she started seeing prickly red dots. At first, she thought they were mosquito bites. She then broke out on her arms and legs. They were mainly there with a few scattered on her arm, legs and torso and they were hives. They were not going away. Her skin was itchy. On 06Aug2021 she also noticed that it seemed like she had difficulty taking deep breaths. She did not pay much mind to difficulty taking deep breaths. She noticed and said it was strange and was just keeping an eye on it. She thought to herself, why was this happening. She does have seasonal allergies. In line with this, caller would like to have recommendations about this as she feels reluctant to take the second dose of the vaccine considering the side effects she experienced during her first dose. The outcome of Left sore arm where she got injection was unknown. The outcome of other events was not recovered  Warm transferred caller to (withheld), Provided caller with phone of (withheld)  Follow-up attempts were completed. No further information was expected.
J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/20/2021 HX OF COVID-19 DISEASE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/20/2021 ACUTE PULMONARY EMBOLISM J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/20/2021 PULMONARY EMBOLISM, UNSPECIFIED.
My father developed high fevers a day after the forced Pneumonia vaccine was given to him. This was given to him without asking our authorization or making us sign any kind of paper. He begun to go on himself constantly and we were told he developed Colitis, which he did not have. He also was given blood transfusions constantly because they told us he was weak and he would have benefited from the transfusions. A week after receiving the Pneumonia Vaccine he had a massive stroke. Nothing was done to diagnose and prevent it. The doctors who kept on coming in said that he was very very sick and everyone was shaking their heads. When we saw how badly he was doing we even asked what they did to him? His personal physician said he was given a Pneumonia Vaccine which was very, very good! This is what he told us and he quickly walked out of the room. On July 27th he was moved to Meadowlands Hospital in Secaucus. After they moved him to Meadowlands Hospital a doctor asked me, why they did not operate on his brain to relieve the pressure and stop the stroke. We were told he did not have colitis, but Sepsis. His blood stream had become completely poisoned. He died on August 14th, two days after we pulled the breathing tube away from him because they told us he was brain dead and there was no hope that he would ever come out of it.
WHO: VR-See above, Vaccinator-, Admin-Sgt , OIC-l, Medical Provider- WHAT: Pt received half dose of her second Moderna due to equipment failure regarding needle and syringe connection. Pt educated to wait 2 weeks and get a lab drawn to see whether she has covid antibodies and if she does not, she could then get another dose if she desires. WHERE: Station 2 WHEN: See above WHY: Equipment failure due to poor quality of needles given.
received Shingrix shot #1 but failed get shot #2 within the 6 month window; This non-serious case was reported by a physician via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (on an unknown date received 1st dose).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received Shingrix shot #1 but failed get shot #2 within the 6 month window).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 14-SEP-2023 The reporter reported that she was unaware that she should report asymptomatic event of a patient failing to get the Shingrix 2nd shot within the six month window.  She stated different doctors have informed her numerous times that a patient has received Shingrix shot1 but failed get shot 2 within the 6 month window (or at all). GSK field representative did not recall specific dates when she learned of these events but it was over 24 hours ago therefore I am putting yesterday's date. Till the date of reporting the patient did not received2nd dose, which led to incomplete course of vaccination. The reporter did not consent to follow-up. The case is linked with US2023127597, US2023127596, by same reporter.; Sender's Comments:  US-GSK-US2023127597:Same reporter US-GSK-US2023127596:Same reporter
6/26/08 @ 2:30pm- vaccine given; @ 6:30pm had moderate tenderness at vaccine site. 10/27/08 @ 6:30am had edema, tenderness, warmth and red welt-like area approximently 6cm diameter at injection site; pain in deltoid with any movement. 12:30pm took oral benadryl 25mg and continued every 6 hours x 3 days. 10-29-08 - edema less but now moderate itch @ site. 10-31-08. No swelling or itch
redness at the site where the shot was and it''s kind of spread out like a rash; redness at the site where the shot was and it''s kind of spread out like a rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 22Sep2021 (Batch/Lot number: unknown) at the age of 73 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE RASH (non-serious), outcome "unknown" and all described as "redness at the site where the shot was and it''s kind of spread out like a rash".  Additional information: It was reported that she asked if this was normal or should she be worried and had not yet reported this to her doctor.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache next day continuous and Swelling of left arm, the size of a baseball, 8 days after vaccine, Red and Hot followed by extreme fatigue and body aches.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. During 2014, the patient was inoculated (by an unspecified person) at a medical clinic with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route of administration, site of administration and lot # were not provided). The vaccine did not prevent shingles as intended. On or about 29-APR-2016, the female patient was treated (by an unspecified healthcare professional) at the hospital for the blistering outbreak and decreased immune symptoms which was then diagnosed as perineal shingles. On or about 02-MAY-2016, the patient sought subsequent treatment at the hospital for the diagnosis of vaginal shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.
Immunization given at 10:00am. Cried with shot , slept until 12 noon, feel well, given tylenol 1:45 coughed began crying with high pitched hoalse cry. Irritable no other findings
Flu vaccine administered on 10/19/2023 at approximately 0915, IM in the left deltoid. At approximately 0925-0930, Patient had c/o of numbness and tingling in the left side of her body with pain/stiffness in her neck. She began vomiting. Worried about a possible serious adverse/anaphylactic reaction, patient was sent to Emergency Department. Patient denies any allergies or similar prior episodes. While not expected to be an allergic reaction, patient received Solumedrol 125mg IV x1, Benadryl 25mg IV x1, NS bolus, ondansetron 4mg IV x1, and famotidine 20mg IV x1.  Patient remained medically stable and was discharged from ED on 10/19/2023.
Focal cutaneous and subcutaneous inflammation; erythema; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 09Oct2021 12:00 (Lot number: FE3590) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes Type 1" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing); "hypertension" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Macrolide antibiotics, reaction(s): "known allergies: Macrolide antibiotics"; Ace inhibitors, reaction(s): "known allergies: ACE inhibitors". Vaccination history included: Bnt162b2 (prev dose product=COVID 19, prev dose brand=Pfizer , prev dose brand unknown=False, prev dose lot number=EL9264, prev dose lot unknown=False, prev dose administration date=02Feb2021, prev dose dose number=1, prev dose vaccine location=Left arm), administration date: 02Feb2021, when the patient was 65 years old, for Covid immunization; Bnt162b2 (prev dose product=COVID 19, prev dose brand=Pfizer , prev dose brand unknown=False, prev dose lot number=EN6198, prev dose lot unknown=False, prev dose administration date=25Feb2021 , prev dose administration time=04:00 PM , prev dose dose number=2, Prev dose vaccine location=Left arm), administration date: 25Feb2021, when the patient was 65 years old, for Covid immunization; Duck embryo rabies vaccine, reaction(s): "known allergies: duck embryo rabies vaccine". The following information was reported: INFLAMMATION (non-serious) with onset 09Oct2021 18:00, outcome "recovering", described as "Focal cutaneous and subcutaneous inflammation"; ERYTHEMA (non-serious) with onset 09Oct2021 18:00, outcome "recovering", described as "erythema". Therapeutic measures were not taken as a result of inflammation, erythema.  No follow-up attempts are possible. No further information is expected.
In early October I started having irritability, panic attacks, weight loss, trouble sleeping.  I choose not to seek help at first thinking it would go away and resolve with time. It progressively got worse over time. I am not sure it this just coincides with my getting the vaccine at the same time or life changes. I started seeing my doctor and we have talked about what I am going through and prescribed some medication. I am waiting on things to get better.
On 8/21/07 developed fever and a few small red raised papules on abd and trunk. She then awoke 8/22/07 with a diffuse rash trunk and extremities - no fever - no other physical concerns.
Sore left arm , nausea, poor appetite for breakfast & fatigue, then at lunchtime ate  small meal, & dinner had soup, but when I took shower noticed lump size of small egg & soft in my left axilla area, now it?s day 5 & still have it , maybe a tiny bit smaller but definitely prominent.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: Patient states difficulty breathing and SpO2 using pulse oximeter was at 91. Epipen given due to patient stating hardness of breathing and low BP.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age. On 09-JUL-2013 the patient was vaccinated with PROQUAD (Merck) 0.5 ml, subcutaneously, lot# unspecified. The reporter stated that the PROQUAD (Merck) was stored at 46F for 10 days. The reporter also states that the PROQUAD (Merck) was put into the refrigerator on 09-JUL-2013. No adverse effect reported. The outcome of the patient was unknown. This is one of several reports received from the same source. Additional information has been requested.
Why did my family get covid? We've all had vax + booster. Your shots don't work.; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Why did my family get covid? We've all had vax + booster. Your shots don't work."; COVID-19 (medically significant), outcome "unknown", described as "COVID-19".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient had vaccines 8/12/15 now had red and swollen right arm. Seemed worse 8/13/15 evening, has been itchy. No fever. Good use of arm, no oozing or drainage. Area seems less inflamed now than yesterday. Got ibuprofen. Area is red, oval 3x5 cm mildly tender macular on (R) upper arm at site of MMRV injection.
elevated AST/ALT 45/55 on 10/26/2022 & 32/51 on 5/4/2022 elevated monocyte count 10/26/2022 0.9 & 1.0 on 5/4/2022
This case was reported by a physician via call center representative and described the occurrence of numbness in fingers in a 58-year-old female patient who received SHINGRIX. On 15th April 2018, the patient received SHINGRIX. On 15th April 2018, less than a day after receiving SHINGRIX, the patient experienced numbness in fingers, hypersensitivity, tingling of extremity and neuropathy. On an unknown date, the outcome of the numbness in fingers, hypersensitivity, tingling of extremity and neuropathy were unknown. It was unknown if the reporter considered the numbness in fingers, hypersensitivity, tingling of extremity and neuropathy to be related to SHINGRIX. Additional information was received as follows: The physician reported that the patient received a SHINGRIX at Pharmacy on 15th April 2018 and was experiencing tingling on fingers, numbness in fingers (the 2nd to 5th fingers) and on latter side of palm (all on the same side the injection was given) and also hypersensitivity of nerves and possible neuropathy. These symptoms started on the day she received the vaccine and were still persisting. No further information was provided.
High fever after 4 days; swollen and red arm; severe pain at site of injection.  When condition got worse went to see primary care on 11/15/2018; she told me I developed a severe life threatening infection due to bacteria on my arm.  Given Bactrim 160 mg. twice daily on 11/15/2018 for seven days.  Unknown to me, I was highly allergic to bactrium and ended up hospitalized with kidneys beginning to shut down because of Bactirum
Pt. had site reaction to VARIVAX. Red and swollen 10 days after injection was given.
tested positive with Covid-19; tested positive with Covid-19; The initial case was missing the following minimum criteria: Unspecified AE. Upon receipt of follow-up information on (13Jun2022), this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group, Program ID: (172086). The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "tested positive with Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: was tested positive with Covid-19. Therapeutic measures were taken as a result of covid-19. Patient tested positive with Covid-19 on her second day of symptoms and was able to staff Paxlovid on Monday 06Jun and Paxlovid works properly for her. Patient had finished with all the covid-19 vaccine.   Follow-up attempts are completed. No further information is expected.
pt recv vax; devel varicella;1st papule noted on rt ear lobe;